Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Crohn Disease
New Crohn disease study results from University of Milan described
June 21st, 2009
According to a study from Milan, Italy, "Assessing perianal disease activity is important for the treatment and prognosis of Crohn's disease (CD) patients, but the diagnostic accuracy of the activity indices has not yet been established. The aim of this study Was to determine the accuracy and agreement of the Fistula Drainage Assessment (FDA)." "Perianal Disease Activity Index (PDAD1), and computer-assisted anal ultrasound imaging (AUS). Sixty-two consecutive patients with CD and perianal fistulae underwent clinical, FDA, PDAI, and AUS evaluation. Perianal disease was considered active in the presence of visible fistula drainage and/or signs of local inflammation...
Source: Medical Letter on the CDC & FDA (2009-06-21)
|
